Because tau pathology precedes symptomatic cognitive deficits by many years [69] and is linked to mild behavioural impairment in preclinical AD [70], an early intervention targeting nutrient‐dependent risk factors such as deficiencies in one‐carbon metabolism could provide a safe and plausible option to decrease the onset and progression of p‐Tau pathology. This evidence concerns the gene MAPT and Alzheimer disease.